Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.00
Bid: 110.00
Ask: 110.80
Change: -0.60 (-0.54%)
Spread: 0.80 (0.727%)
Open: 110.20
High: 110.80
Low: 110.00
Prev. Close: 110.60
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Tue, 26th Jul 2022 15:57

Wednesday 27 July 
Allied Minds PLCAGM
Caledonia Investments PLCAGM
De La Rue PLCAGM
FirstGroup PLCAGM
James Cropper PLCAGM
JPMorgan Japan Small Cap Growth & Income PLCAGM
Mode Global Holdings PLCAGM
Montanaro UK Smaller Cos Investment Trust PLCAGM
Motorpoint Group PLCAGM
Shield Therapeutics PLCAGM
Tatton Asset Management PLCAGM
Thursday 28 July 
B&M European Value Retail SAAGM
Braemar Shipping Services PLCAGM
CMC Markets PLCAGM
CMC Markets PLCGM re proposed related party transaction
CYBA PLCAGM
De La Rue PLCAGM
discoverIE Group PLCAGM
Eight Capital Partners PLCAGM
Eurasia Mining PLCAGM
GB Group PLCAGM
Global Smaller Companies Trust PLCAGM
Graft Polymer (UK) PLCAGM
Ingenta PLCAGM
Mediclinic International PLCAGM
Octopus Renewables Infrastructure Trust PLCGM re investing in offshore wind farms in core focus
Oxford Instruments PLCAGM
RentGuarantor Holdings PLCAGM
Tate & Lyle PLCAGM
Ted Baker PLCAGM
Friday 29 July 
Eneraqua Technologies PLCAGM
Global Ports Holding PLCGM re elections of Ajini and Iosifakis as directors
Palace Capital PLCAGM
ProCook Group PLCAGM
Record PLCAGM
Rogue Baron PLCAGM
Sirius Real Estate LtdAGM
Standard Chartered PLCGM re approving HY announcement, interim dividend
Monday 1 August 
Cranswick PLCAGM
Tuesday 2 August 
Caffyns PLCAGM
Syncona LtdAGM
Tanfield Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 Feb 2023 09:45

Syncona net asset value falls on "challenging" market, dollar weakness

(Alliance News) - Syncona Ltd on Tuesday reported a decline in its third quarter net asset value, noting a depreciating US dollar against sterling and a decline in the share price of investees.

Read more
7 Feb 2023 07:16

Syncona NAV falls in Q3

(Sharecast News) - Healthcare company Syncona said on Tuesday that net assets had fallen in the three months ended 31 December, principally due to the declining value of its quoted holdings and foreign exchange fluctuations.

Read more
25 Jan 2023 12:14

Life Science REIT lets second floor of Rolling Stock Yard in London

(Alliance News) - Life Science REIT PLC on Wednesday said it signed an agreement to lease the second floor of its Rolling Stock Yard asset near King's Cross, London, to a life science company backed by Syncona Ltd.

Read more
22 Dec 2022 08:04

Syncona investee Autolus sells more American shares

(Sharecast News) - Life science-focussed healthcare company Syncona said on Thursday that its portfolio company Autolus Therapeutics had announced that the underwriters of its public offering of American depositary shares (ADSs), which closed on 13 December, had partially exercised their option to purchase an additional 6,927,102 ADSs.

Read more
9 Dec 2022 10:36

Syncona portfolio firm hits 70% remission rate goal in leukaemia trial

(Alliance News) - Syncona Ltd on Friday said portfolio company Autolus Therapeutics PLC achieved the primary endpoint in the clinical trial of its treatment for acute lymphoblastic leukaemia.

Read more
9 Dec 2022 07:21

Syncona's Autolus leukemia treatment meets trial endpoint

(Sharecast News) - Syncona portfolio company Autolus Therapeutics announced that a phase 2 clinical trial in adult acute lymphoblastic leukemia (ALL) patients has met its primary endpoint at interim analysis.

Read more
6 Dec 2022 12:00

Syncona investee Achilles continues to progress cancer trials

(Alliance News) - Syncona Ltd on Tuesday noted the continued positive progress in lung cancer trials by its portfolio company.

Read more
1 Dec 2022 10:16

Syncona's Achilles says cancer treatment shows promise; seals buy

(Alliance News) - Syncona Ltd on Thursday noted a promising safety profile for a cancer therapy concocted by one investee, and separately announced the completion of an acquisition in the retinal gene therapy space.

Read more
29 Nov 2022 09:05

TOP NEWS: AstraZeneca to buy Neogene for cancer treatment

(Alliance News) - AstraZeneca PLC said it agreed to buy Neogene Therapeutics Inc for the treatment of cancer, as also noted by healthcare company Syncona Ltd on Tuesday.

Read more
29 Nov 2022 08:57

LONDON MARKET OPEN: Stocks up as protests in China deterred by police

(Alliance News) - The FSTE 100 opened in the green on Tuesday as investors were reassured that civil unrest in China would be short lived amid unyielding action by the authorities.

Read more
29 Nov 2022 07:50

LONDON BRIEFING: easyJet boasts "record bounce back" as loss narrows

(Alliance News) - Stocks in London were set to open slightly higher on Tuesday as unrest in the world's second largest economy continued.

Read more
17 Nov 2022 10:53

Syncona net assets rise in half year and outlines 10-year growth plans

(Alliance News) - Syncona Ltd on Thursday said net assets increased in the first half of its financial year, as it outlined plans to grow its net assets to GBP5 billion within the next 10 years.

Read more
17 Nov 2022 08:16

Syncona makes 'positive' operational and clinical progress in H1

(Sharecast News) - Healthcare company Syncona said on Thursday that it had delivered "positive operational and clinical progress" across its portfolio against a challenging macro backdrop in the six months ended 30 September.

Read more
15 Nov 2022 14:41

IN BRIEF: Syncona notes investee Freeline's third-quarter loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes third-quarter results of investee Freeline Therapeutics Holdings PLC. Freeline's pretax loss in the third quarter that ended September 30 narrows to USD65.9 million from USD105.7 million a year prior. Research & development expenses decrease to USD53.6 million from USD70.8 million, and total operating expenses fall by 27% to USD78.6 million from USD108.0 million. Freeline continues to make no revenue. Freeline enters a definitive agreement to sell its chemistry, manufacturing & control focused German subsidiary and related intellectual property for USD25 million, with the sale being subject to price adjustments.

Read more
10 Nov 2022 21:19

TRADING UPDATES: Zambeef expects profit jump; Mobile Streams wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.